Increasing Academic and Commercial R&D Spending on Pharmaceuticals
The pharmaceutical industry holds the largest market share of the chromatography resins market. Hence, fluctuations in the pharmaceutical industry, worldwide, directly affects the demand for chromatography resins. In the pharmaceutical industry, chromatography resins are used for a wide variety of applications, including separation of chemical and biomolecules, for drug delivery, protein purification, diagnostics, etc. With the increasing number of diseases around the world, increasing cases of AIDS and cancer research, and discovery of new viruses, and bacteria, industries have called for development of newer molecular entities (NMEs) to combat these diseases; they have increased their R&D spending on medicines. With rising critical diseases across the world, monoclonal antibody therapeutics is quickly gaining importance, which directly employs the use of chromatography resins.
Pharmaceuticals to Dominate the Market
Chromatography resins are high performance resins, widely employed in liquid chromatography technique. The utility in separation and analysis of biomolecules based on their biological functions or individual structures in the pharmaceutical industry and biotechnology is growing in popularity. Liquid chromatography technique is becoming increasingly important as a useful separation method in pharmaceutical science, biochemistry, biotechnology, and environmental science in the recent years. This technique is known as the most specific and effective technique for protein purification. Separation of biomolecules is based on highly-specific biological interactions between two molecules, such as enzymes and substrates. The application of chromatography resins in the drug production application is increasing in Asia-Pacific, owing to huge investments made by governments of developing economies in drug production and pharmaceutical activities, especially in India and China.
Japan to Dominate the Market
In 2017, Japan held the highest market share, accounting for more than 55% of the Asia-Pacific market. The Japanese market is highly driven by the pharmaceutical industry. On account of extensive pharmaceutical R&D in the country, the sector is likely to stimulate the growth of the chromatography resins market in the country. Increasing demand for economical drugs from the rising aging population of the country has opened the gateway of new market avenues for the pharmaceutical industry. Availing this new opportunity, expected developments in the pharmaceutical industry is likely to drive the chromatography resins market in Japan.
Key Developments in the Market
November 2017: Purolite collaborated with Repligen Corporation, involved in the line of pre-packed chromatography columns.
September 2017: Thermo Fisher Scientific Inc. launched PureLink Fast Low-Endotoxin Plasmid Purification Midi and Maxi Kits, which is used to accelerate the process of isolation of plasmid DNA.
March 2017: Tosoh Bioscience launched TOYOPEARL AF-rProtein L-650F, a protein L resin that exhibits high-binding capacity.
Major Players: Thermo Fisher Scientific Inc., Merck KGaA, Tosoh Bioscience LLC, Bio-Rad Laboratories, Inc., Pall Corporation, and Avantor Performance Materials, LLC, amongst others.
Reasons to Purchase the Report
Analyzing how the increasing academic and commercial R&D spending on pharmaceuticals will drive the market
Analyzing various perspectives of the market with the help of Porter’s five forces analysis
The origin, technology, and application that are expected to dominate the market
The region that is expected to witness the fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3-month analyst support, along with the Market Estimate sheet in excel
Customization of the Report
This report can be customized to meet your requirements.
Along with the customization, we also have an individual report on Global Chromatography Resins Market.
1.1 Research Phases
1.2 Study Deliverables
1.3 Scope of the Report
2. Executive Summary
3. Market Insights
3.1 Industry Value Chain Analysis
3.2 Industry Attractiveness - Porter’s Five Forces Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products and Services
3.2.5 Degree of Competition
4. Market Dynamics
4.1.1 Increasing Academic and Commercial R&D Spending on Pharmaceuticals
4.1.2 Technological Advancements in Chromatography Resins
4.1.3 Growing Importance of Chromatography Tests in Drug Approvals
4.2.1 High Costs vs. Productivity of Chromatography Systems
4.2.2 Other Restraints
4.3.1 Rising Importance of Green Chromatography
4.3.2 Other Opportunities
5. Market Segmentation and Analysis (Market Size, Growth, and Forecast)
5.1 By Origin
126.96.36.199 Silica Gel
188.8.131.52 Aluminum Oxide
5.2 By Technology
5.2.1 Ion Exchange Chromatography Resins
5.2.2 Affinity Chromatography Resins
5.2.3 Lectin Affinity Chromatography
5.2.4 Hydrophobic Interaction Chromatography Resins
5.2.5 Mixed-mode Chromatography Resins
5.3 By Application
184.108.40.206 Drug Discovery
220.127.116.11 Drug Production
5.3.2 Food & Beverage
5.3.3 Water & Environmental Analysis
6. Regional Market Analysis (Market Size, Growth, and Forecast)
6.4 Rest of Asia-Pacific
7. Competitive Landscape
7.1 Mergers & Acquisitions, Joint Ventures, Collaborations and Agreements
7.2 Market Share Analysis**
7.3 Strategies Adopted by Leading Players
8. Company Profiles (Overview, Financials**, Products & Services, Recent Developments, and Analyst View)
8.1 Agilent Technologies
8.2 Avantor Performance Materials, LLC
8.3 Bio-Rad Laboratories, Inc.
8.4 GENERAL ELECTRIC
8.5 Mitsubishi Chemical Corporation
8.6 Merck KGaA
8.7 Pall Corporation
8.8 PerkinElmer Inc.
8.10 REPLIGEN CORPORATION
8.11 The Dow Chemical Company (DowDuPont)
8.12 Thermo Fisher Scientific Inc.
8.13 Tosoh Bioscience LLC
8.14 *(List Not Exhaustive)
**Subject to availability on public domain
- Affymetrix Inc.
- Agilent Technologies
- BASF SE
- Bio-Rad Laboratories Inc.
- GE Healthcare Life Sciences
- Merck KGAA
- Mitsubishi Chemical Corporation
- Pall Corporation
- Perkinelmer Inc.
- Siemens AG
- Sigma-Aldrich Corporation
- Thermo Fisher Scientific Inc.
- Tosoh Corporation